Literature DB >> 10368679

Cell surface expression of urokinase receptor in normal mammary epithelial cells and breast cancer cell lines.

Y Li1, N Wood, D Yellowlees, P K Donnelly.   

Abstract

BACKGROUND: The urokinase receptor (uPAR) is important in the process of extracellular matrix degradation occurring during cancer cell invasion and metastasis. We wished to quantify uPAR on the surfaces of normal mammary epithelial cells (HMEC) and 6 well-known breast cancer cell lines using flow cytometry.
MATERIALS AND METHODS: Cell surface uPAR was labelled with a monoclonal antibody, and this was detected with a fluorescent-labelled second antibody and accurately measured using flow cytometry. The measured fluorescent signals of the stained cells were interpolated with those of Quantum Simply Cellular bead standards to determine the number of uPAR sites per cell.
RESULTS: The breast cancer cell lines ranged from 13,700 to 50,800 uPAR sites per cell, whilst HMEC cells had only 2,500 sites.
CONCLUSIONS: This simple and reliable method showed that the expression of cell surface uPAR is higher in the breast cancer cell lines than in the normal mammary cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10368679

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging.

Authors:  Lily Yang; Zehong Cao; Hari Krishna Sajja; Hui Mao; Liya Wang; Huaying Geng; Hengyi Xu; Tieshan Jiang; William C Wood; Shuming Nie; Y Andrew Wang
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

2.  Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.

Authors:  Bénédicte Chazaud; Rémy Ricoux; Christo Christov; Anne Plonquet; Romain K Gherardi; Georgia Barlovatz-Meimon
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents.

Authors:  Lei Xi; Stephen R Grobmyer; Guangyin Zhou; Weiping Qian; Lily Yang; Huabei Jiang
Journal:  J Biophotonics       Date:  2012-11-02       Impact factor: 3.207

4.  Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

Authors:  Lily Yang; Xiang-Hong Peng; Y Andrew Wang; Xiaoxia Wang; Zehong Cao; Chunchun Ni; Prasanthi Karna; Xinjian Zhang; William C Wood; Xiaohu Gao; Shuming Nie; Hui Mao
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531

5.  uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.

Authors:  Lily Yang; Hari Krishna Sajja; Zehong Cao; Weiping Qian; Laura Bender; Adam I Marcus; Malgorzata Lipowska; William C Wood; Y Andrew Wang
Journal:  Theranostics       Date:  2013-12-17       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.